Azur Pharma Inc.

15 articles about Azur Pharma Inc.

• Jazz Pharmaceuticals, Inc. and Azur Pharma Inc. Combine to Create Jazz Pharmaceuticals plc

  1/18/2012

• Jazz Pharmaceuticals, Inc. to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Inc. Transaction

  1/4/2012

• Azur Pharma Inc. Release; 2011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management

  12/19/2011

• Jazz Pharmaceuticals, Inc. Announces Stockholder Vote in Favor of Transaction With Azur Pharma Inc.

  12/13/2011

• Jazz Pharmaceuticals, Inc. Soars as Analyst Praises Move to Buy Azur Pharma Inc.; Companies Combine to Form Jazz Pharmaceuticals plc

  9/20/2011

• BioSante Pharmaceuticals, Inc. Reports Receipt of $2.16 Million in Elestrin(TM) Royalty Buydown With Azur Pharma Inc., and Financial Results for 2009

  3/30/2010

• Azur Pharma Inc. to Acquire Elan Corporation PLC's Painkiller Prialt

  3/12/2010

• Azur Pharma Inc. Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan CNS/Pain Specialty Infrastructure

  3/11/2010

• Azur Pharma Inc. Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB Two Marketed CNS Products With U.S. Revenues of $20 Million Two FDA Approved but Unlaunched Products

  1/9/2009

• Antares Pharma, Inc. Receives Milestone Payment and Additional Patent Related to Elestrin(R)

  1/6/2009

• Azur Pharma Enters Into Definitive Agreement With BioSante Pharmaceuticals, Inc. to Acquire U.S. Rights to Elestrin (TM)

  12/4/2008

• Azur Pharma and Elan Corporation PLC (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine

  11/10/2008

• IntelGenx Technologies Corp. Forms Strategic Agreement with Azur Pharma to Develop Prenatal Vitamin Supplements Addressing a U.S. Market of $250 Million

  1/7/2008

• Azur Pharma Completes Equity Financing for US$48 Million

  8/7/2007

• Azur Pharma Announces the Acquisition of Pharmelle LLC; Adds 35 Person U.S. Sales Force

  2/26/2007